As of the most recent numbers, over 100 million Americans have received at least one dose of the COVID vaccination.
Of that number, approximately 75 million have been fully vaccinated. This should help the country get back to normal relatively soon given that number plus the number of people who have already had the virus and have immunity to it.
The vaccination from Johnson & Johnson is a one-dose shot and is much more appealing to many people because you would only have to get one injection instead of two, therefore you would have immunity sooner.
However, there has been a very serious side effect discovered in relation to the Johnson & Johnson vaccine and now the FDA and the CDC have both called for the administration of that version to be put on pause immediately.
The FDA tweeted the following:
Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution.
As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare.
Treatment of this specific type of blood clot is different from the treatment that might typically be administered.
CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.
Until that process is complete, we are recommending this pause. This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot.
Johnson & Johnson said in a statement:
“We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines. At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine.”